In this randomized clinical trial of 177 children with intermittent exotropia, a 12-week home-based virtual reality vision therapy program led to a modest but statistically significant improvement in distance exotropia control compared with observation, with greater benefits observed among patients with at least 75% adherence. No treatment-related adverse events were reported, suggesting virtual reality vision therapy may offer a safe, nonsurgical adjunct for selected pediatric patients, although the clinical magnitude of improvement was limited and longer-term outcomes remain under investigation.

Source: JAMA Network Open